Items without sitelinks
From determinar.ia.br - Determine suas informações
Showing below up to 50 results in range #16,551 to #16,600.
- Niemann-Pick disease type C, severe perinatal (Q96259)
- Postprocedural complete heart block, unintentional (Q96258)
- Burn of eyelid (Q96257)
- Exposure to or harmful effects of undetermined intent of mineral salts, not elsewhere classified (Q96256)
- Swimmer's ear (Q96255)
- Chemical burn of conjunctiva (Q96254)
- Cyst of canthus (Q96253)
- Exposure to or harmful effects of undetermined intent of other diuretics (Q96252)
- Acute bacterial inflammation of external ear (Q96251)
- Exposure to or harmful effects of undetermined intent of bisphosphonates (Q96250)
- Exposure to or harmful effects of undetermined intent of electrolytic, caloric or water-balance agents (Q96249)
- Greenstick fracture of shaft of humerus (Q96248)
- Bohn nodules (Q96247)
- Myelopathy due to delayed radiation (Q96246)
- Exposure to or harmful effects of undetermined intent of carbonic-anhydrase inhibitors (Q96245)
- Chemical burn of cornea (Q96244)
- Postprocedural complete heart block, intentional (Q96243)
- Exposure to or harmful effects of undetermined intent of drugs affecting uric acid metabolism (Q96242)
- Exposure to or harmful effects of undetermined intent of loop diuretics (Q96241)
- Exposure to or harmful effects of undetermined intent of vitamin D or derivatives (Q96240)
- Burn of periocular area (Q96239)
- Burn of conjunctiva (Q96238)
- Dental lamina cyst of the newborn (Q96237)
- Myelopathy due to early radiation (Q96236)
- Burn of cornea (Q96235)
- Exposure to or harmful effects of undetermined intent of mineralocorticoids antagonists (Q96234)
- Exposure to or harmful effects of undetermined intent of benzothiadiazine derivatives (Q96233)
- Exposure to or harmful effects of undetermined intent of other coronary vasodilators (Q96232)
- Exposure to or harmful effects of undetermined intent of other antihypertensive drugs (Q96231)
- Exposure to or harmful effects of undetermined intent of sulfonamides (Q96230)
- Exposure to or harmful effects of undetermined intent of antiviral drugs (Q96229)
- Exposure to or harmful effects of undetermined intent of anthelminthics (Q96228)
- Exposure to or harmful effects of undetermined intent of peripheral vasodilators (Q96227)
- Exposure to or harmful effects of undetermined intent of antivaricose drugs, including sclerosing agents (Q96226)
- Exposure to or harmful effects of undetermined intent of angiotensin-converting-enzyme inhibitors (Q96225)
- Exposure to or harmful effects of undetermined intent of mineralocorticoids (Q96224)
- Exposure to or harmful effects of undetermined intent of antimalarials or drugs acting on other blood protozoa (Q96223)
- Exposure to or harmful effects of undetermined intent of other antiprotozoal drugs (Q96222)
- Exposure to or harmful effects of undetermined intent of antihyperlipidemic or antiarteriosclerotic drugs (Q96221)
- Exposure to or harmful effects of undetermined intent of antimycobacterial drugs (Q96220)
- Exposure to or harmful effects of undetermined intent of nitroglycerin, nitroglycerol, medicinal (Q96219)
- Exposure to or harmful effects of undetermined intent of camphor (Q96218)
- Exposure to or harmful effects of undetermined intent of other antidysrhythmic drugs (Q96217)
- Exposure to or harmful effects of undetermined intent of antidiarrhoeal drugs (Q96216)
- Exposure to or harmful effects of undetermined intent of methyl salicylate (Q96215)
- Exposure to or harmful effects of undetermined intent of other local antifungal, anti-infective or anti-inflammatory drugs (Q96214)
- Exposure to or harmful effects of undetermined intent of podophyllin (Q96213)
- Exposure to or harmful effects of undetermined intent of silver nitrate (Q96212)
- Exposure to or harmful effects of undetermined intent of cardiac-stimulant glycosides or drugs of similar action (Q96211)
- Exposure to or harmful effects of undetermined intent of emetics (Q96210)
